Antibacterial Activity of New Rimantadine Derivatives, Conjugated with Compact and Bulky Amino Acids
References
- European Commission. Opinion of the scientific panel on additives and products or substances used in animal feed on the updating of the criteria used in the assessment of bacteria for resistance to antibiotics of human or veterinary importance. The EFSA J. 2005; 223: 1-12.
- Oliveira M, Antunes W, Mota S, Madureira-Carvalho A, Dinis-Oliveira RJ, da Silva DD. An overview of the recent advances in antimicrobial resistance, Microorganisms 2024; 12: 1920.
- Tencheva A, Stankova I, Angelova Ts, Nemska V, Georgieva N, Danalev D. Antimicrobial activity of amino acid derivatives of memantine. J Chem Technol Metall. 2022; 57: 286-290.
- Mondal D. Rimantadine, Reference Module in Biomedical Sciences, Elsevier 2016, doi: 10.1016/B978-0-12-801238-3.99410-8.
- Deyde VM, Xu X, Bright RA, Shaw M, Smith C.B, Zhang Y, Shu Y, Gubareva LV, Cox NJ, Klimov AI. Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide. J Infect Dis. 2007; 196: 249–257.
- Paintsil E, Cheng Y-C. Antiviral Agents, In Encyclopedia of Microbiology, 3rd ed.; Schaechter, M., Eds.; Academic Press, 2009; 223-257.
- Vorobjev YN. An effective molecular blocker of ion channel of M2 protein as anti-influenza A drug, J. Biomol Struct Dyn. 2021; 39: 2352-2363.
- Zlydnikov DM, Kubar OI, Kovaleva TP, Kamforin LE. Study of Rimantadine in the USSR: a review of the literature. Rev Infect Dis. 1981; 3: 408-421.
- Miyauchi S, Sanders PD, Guram K, Kim SS, Paolini F, Venuti A, Cohen EEW, Gutkind JS, Califano JA, Sharabi AB. HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer. Cancer Res. 2020; 15: 732-746.
- Kelly JM, Miles MA, Skinner AC. The Anti-Influenza Virus Drug Rimantadine Has Trypanocidal Activity. Antimicrob. Agents Chemother. 1999; 43: 985-987.
- CDC, 2023, Influenza antiviral medications: summary for clinicians. Available online: https://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.html (accessed on 25 February 2026).
- Zoidis G, Kolocouris N, Foscolos GB, Kolocouris A, Fytas G, Karayannis P, Padalko E, Neyts J, de Clercq E. Are the 2-Isomers of the Drug Rimantadine Active Anti-Influenza a Agents? Antivir Chem Chemother. 2003; 14: 153-164.
- Stamatiou G, Foscolos G.B, Fytas G, Kolocouris A, Kolocouris N, Pannecouque C, Witvrouw M, Padalko E, Neyts J, De Clercq E. Heterocyclic rimantadine analogues with antiviral activity. Bioorg. Med Chem. 2003; 11: 5485–5492.
- Zoidis G, Fytas C, Papanastasiou I, Foscolos GB, Fytas G, Padalko E, De Clercq E, Naesens L, Neyts J, Kolocouris N. Heterocyclic rimantadine analogues with antiviral activity. Bioorg. Med Chem. 2006; 14(10): 3341-3348.
- Chayrov R, Parisis NA, Chatziathanasiadou MV, Vrontaki E, Moschovou K, Melagraki G, Sbirkova-Dimitrova H, Shivachev B, Schmidtke M, Mitrev Y, Sticha M, Mavromoustakos T, Tzakos AG, Stankova I. Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors – In Vitro, In Silico and QSAR Studies. Molecules. 2020; 25: 3989.
- Knorr R, Trzeciak A, Bannwarth W, Gillessen D. New coupling reagents in peptide chemistry. Tetrahedron Lett. 1989; 30: 1927–1930.
- CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute, 2018.
- Lei J, Sun L, Huang S, Zhu C, Li P, He J, Mackey V, Coy DH, He Q, The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019; 11(7): 3919-3931.
- Pushpanathan M, Gunasekaran P, Rajendhran J. Antimicrobial Peptides: Versatile Biological Properties. Int J Pept. 2013; 1-15.
- Huan Y, Kong Q, Mou H, Yi H. Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields. Front Microbiol. 2020; 11: 582779.
- Xuan J, Feng W, Wang J, Wang R, Zhang B, Bo L, Chen Z-S, Yang H, Sun L. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resist Updat. 2023; 68: 100954.
- Büyükkiraz ME, Kesmen Z., Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds, J Appl Microbiol, 2022; 132(3): 1573-1596.
- Stankova I, Chuchkov K, Chayrov R, Mukova L, Galabov A, Marinkova D, Danalev D. Adamantаne derivatives containing thiazole moiety – synthesis, antiviral and antibacterial activity. Int J Pept Res Ther. 2020; 26(4): 1781-1787.
- Stankova IG, Chayrov RL, Schmidtke M, Danalev DL, Ognichenko LN, Artemenko AG, Shapkin VA, Kuz’min VE. Quantitative structure-activity relationship modelling of influenza M2 ion channels inhibitors. J Serb Chem Soc. 2021; 86 (7-8): 625-637.
- Tencheva A, Stankova I, Angelova T, Nemska V, Georgieva N, Danalev D. Antimicrobial activity of amino acid derivatives of memantine. J Chem Technol Metall. 2022; 57(2): 286-290.
- Rohde M. The Gram-positive bacterial cell wall. Microbiol Spectr. 2019, 7: 10.
- Nunes, LO. Predicting peptide orientation in membrane interations: a review on transmembrane and surface-bound states. Eur Biophys J. 2026; 55: 9-20.
- Le C-F, Fang C-M, Sekaran SD. Intracellular targeting mechanisms by antimicrobial peptides, Antimicrob Agents Chemother. 2017; 61(4): e02340-16.
DOI: https://doi.org/10.2478/ebtj-2026-0012 | Journal eISSN: 2564-615X
Language: English
Page range: 171 - 176
Published on: Jul 23, 2026
Published by: European Biotechnology Thematic Network Association
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Radoslav Chayrov, Antoniya Stoymirska, Kiril Chuchkov, Veronica Nemska, Nelly Georgieva, Dancho Danalev, Ivanka Stankova, published by European Biotechnology Thematic Network Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.